Alternative splicing of FGFR3 as a mechanism for African American prostate cancer health disparities

被引：0
|
作者：
Olender, Jacqueline
Wang, Bi-Dar
Lee, Norman H.
机构：
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2017年 / 26卷 / 02期
关键词：
D O I：
10.1158/1538-7755.DISP16-C42
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C42
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Alternative splicing in prostate cancer
    Paschalis, Alec
    Sharp, Adam
    Welti, Jonathan C.
    Neeb, Antje
    Raj, Ganesh V.
    Luo, Jun
    Plymate, Stephen R.
    de Bono, Johann. S.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (11) : 663 - 675
  • [22] Study of FGFR3 Expression and FGFR3 Mutations in Molecular Subtypes of Muscle Invasive Bladder Cancer
    Kaushal, Seema
    Roy, Charli
    Seth, Amlesh
    Sahoo, Ranjit
    Batra, Atul
    Dinda, Amit
    LABORATORY INVESTIGATION, 2024, 104 (03) : S966 - S967
  • [23] FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer
    Neuzillet, Yann
    van Rhijn, Bas W. G.
    Prigoda, Nadia L.
    Bapat, Bharati
    Liu, Liyang
    Bostrom, Peter J.
    Fleshner, Neil E.
    Gallie, Brenda L.
    Zlotta, Alexandre R.
    Jewett, Michael A. S.
    van der Kwast, Theo H.
    VIRCHOWS ARCHIV, 2014, 465 (02) : 207 - 213
  • [24] FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer
    Yann Neuzillet
    Bas W. G. van Rhijn
    Nadia L. Prigoda
    Bharati Bapat
    Liyang Liu
    Peter J. Bostrom
    Neil E. Fleshner
    Brenda L. Gallie
    Alexandre R. Zlotta
    Michael A. S. Jewett
    Theo H. van der Kwast
    Virchows Archiv, 2014, 465 : 207 - 213
  • [25] Linking African ancestral substructure to prostate cancer health disparities
    Gheybi, Kazzem
    Mmekwa, Naledi
    Lebelo, Maphuti Tebogo
    Patrick, Sean M.
    Campbell, Raymond
    Nenzhelele, Mukudeni
    Soh, Pamela X. Y.
    Obida, Muvhulawa
    Loda, Massimo
    Shirindi, Joyce
    Butler, Ebonee N.
    Mutambirwa, Shingai B. A.
    Bornman, M. S. Riana
    Hayes, Vanessa M.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [26] Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
    Andrew J. Weickhardt
    David K. Lau
    Margeaux Hodgson-Garms
    Austen Lavis
    Laura J. Jenkins
    Natalia Vukelic
    Paul Ioannidis
    Ian Y. Luk
    John M. Mariadason
    BMC Cancer, 22
  • [27] Linking African ancestral substructure to prostate cancer health disparities
    Kazzem Gheybi
    Naledi Mmekwa
    Maphuti Tebogo Lebelo
    Sean M. Patrick
    Raymond Campbell
    Mukudeni Nenzhelele
    Pamela X. Y. Soh
    Muvhulawa Obida
    Massimo Loda
    Joyce Shirindi
    Eboneé N. Butler
    Shingai B. A. Mutambirwa
    M. S. Riana Bornman
    Vanessa M. Hayes
    Scientific Reports, 13
  • [28] Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
    Weickhardt, Andrew J.
    Lau, David K.
    Hodgson-Garms, Margeaux
    Lavis, Austen
    Jenkins, Laura J.
    Vukelic, Natalia
    Ioannidis, Paul
    Luk, Ian Y.
    Mariadason, John M.
    BMC CANCER, 2022, 22 (01)
  • [29] ONCOGENOMIC STUDY ON PROSTATE CANCER DISPARITIES ASSOCIATED WITH THE AFRICAN AMERICAN POPULATION
    Wang, Bi-Dar
    Andrawis, Ramez
    Bianco, Fernando
    Jarrett, Thomas
    Frazier, Harold
    Small, James
    Patierno, Steven
    Lee, Norman
    JOURNAL OF UROLOGY, 2010, 183 (04): : E215 - E215
  • [30] Genomic study on prostate cancer disparities reveals the differential transcriptomes, microRNA profiles, alternative splicing patterns and copy number variations between Caucasian and African American populations
    Wang, Bi-Dar
    Andrawis, Ramez
    Jarret, Thomas
    Bianco, Fernando
    Frazier, Harold
    Patierno, Steven R.
    Lee, Norman H.
    CANCER RESEARCH, 2010, 70
12345